CBER's David Feigal Named FDA Device Center Director May 4
This article was originally published in The Gray Sheet
FDA Commissioner Jane Henney's appointment of David Feigal, Jr., MD/MPH, to head the Center for Devices and Radiological Health once again returns industry to the position of determining whether a new device center director views FDA's regulation of devices in a different light than drugs and biologics.
You may also be interested in...
Senate and House conferees should retain the $7 mil. and 45 FTEs earmarked by the Senate version of the FY 2000 agriculture appropriations bill (S 1233) for medical device reviews, the Health Industry Manufacturers Association urges in a Sept. 13 letter to the Senate Appropriations Committee.
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.